Teva Pharmaceutical Indus Stock (OTC: TEVJF)

Latest News for Teva Pharmaceutical Indus Stock (OTC:TEVJF)

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

AACAY

AAWW

ABBV

ABMD

ACGBF

ACRGF

ADMP

AERI

AGTK

AIBGY

ALKM

ALNA

ALSWF

AMAG

ANGI

APGMF

APNHY

APOP

ARCH

ARLO

ARLP

ARREF

ASRT

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATHOF

ATRA

ATVK

AVNS

AWLCF

AXGN

AXVEF

AZRX

AZZUF

BAFYY

BBCP

BBVA

BBVXF

BCDA

BCEFF

BCEL

BCYC

BDVSY

BEDU

BFIN

BHKLY

BICEF

BIDU

BIOAF

BIREF

BJRI

BKKLY

BKRIF

BKRIY

BLCM

BLMN

BLRX

BNDSF

BNEFF

BPAQF

BPFH

BRKMY

BRTX

BrightSphere Investment Group plc Ordinary Shares

BSIG

BTHE

BUDZ

BWFG

BXEFF

BZLFY

CADE

CAIXY

CAKE

CALX

CARB

CARCY

CARG

CARS

Stocks That Fell Through 52-Week Lows Wednesday

ABEO

ACER

ACGBY

ACOR

ACRS

ADAP

ADBCF

ADPT

AGDXF

AGIO

AHKSY

AKBA

AKCA

ALDR

ALFVF

ALFVY

ALTM

ALTPF

ALXEF

AMCR

AMGDF

AMRX

ANAB

ANDE

APAFF

APEN

APNHF

AQST

AREVF

ARGGY

ASGLY

ASMB

ASNA

AVGR

AVLIF

AWRE

AXAS

AXION VENTURES INC by Axion Ventures Inc.

AXNVF

BACHF

BACHY

BASFY

BBBY

BELFA

BICEY

BJCHF

BNFT

BNKHF

BORR

BOXS

BRVRF

BSET

BVTEF

CAMP

CANL

New 52-Week Lows For Monday Morning

TEVA PHARM INDUS LTD ORD by Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd

Vanda Pharmaceuticals: FDA Approvals On Deck In 2024 Makes This A Must Watch

Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript)

Catalyst Pharmaceuticals: Until The TEVA ANDA Is Resolved, There Is A Risk

Catalyst Pharmaceuticals At A Crossroads: Firdapse Litigation And Agamree's Launch

Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript

Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2023 Update

Week In Review: Mabwell Sells Ex-China Rights To Rare Disease Therapy In $412M Deal

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Teva Pharmaceutical Indus Stock (OTC:TEVJF)

Wednesday, August 07, 2019

Monday, August 05, 2019